The Difference

The C-View 2D image is the world’s first and only synthesized 2D image that is FDA approved to replace FFDM within a combined tomosynthesis screening exam. C–View software’s 2D image is designed to be different. Our advanced algorithm takes high-quality tomosynthesis data and instantly generates 2D images designed to enhance details such as bright spots and linear structures while minimizing tissue overlap. This helps to guide and expedite the tomosynthesis exam review. With any new imaging change, training is critical. Several educational options are available to help you become experienced or acquainted with this unique Low Dose 3D™ Mammogram.

The Evidence

Additionally, the body of clinical evidence on this Low Dose 3D™ Mammogram is growing, demonstrating similar results to the use of Hologic’s traditional 3D Mammogram (Full Field Digital Mammography (FFDM) 2D+Tomosynthesis). Review the evidence in the Resources section.